Business Wire

Advantage Smollan Announces the Acquisition of Hamilton Bright

3.7.2017 18:00 | Business Wire

Jaa

Advantage Smollan, the joint holding company between Advantage Solutions (Advantage) and Global Smollan Holdings (Smollan), announced today its pending acquisition of Hamilton Bright Group B.V., a specialist in sales, brand activation and market intelligence in the Netherlands and Belgium. The completion of the acquisition is subject to customary closing conditions.

Advantage Smollan provides outsourced sales, marketing, and technology solutions for consumer goods manufacturers and retailers in a number of European markets. Hamilton Bright extends Advantage Smollan’s reach into the key markets of the Netherlands and Belgium and provide a unified solution for customers in these countries. Hamilton Bright will continue to operate under its current name.

Laurence Clube, Chief Operating Officer of Advantage Smollan, commented, “I am very excited about Hamilton Bright joining Advantage Smollan. This move brings a high quality business into the group and will enable us to improve and broaden what we do for our customers by sharing best practices.”

“To build Advantage Smollan’s footprint across Europe, we are targeting companies that are number one in their markets and share our entrepreneurial culture and passion for adding value. We have clearly found that in Hamilton Bright,” said Tanya Domier, CEO of Advantage.

David Smollan, Chief Executive Officer of Smollan, added, "We are excited to partner with Hamilton Bright who are a great cultural fit for our group and bring great expertise through their diversified service offerings".

Hamilton Bright was founded in 2000 and holds a client portfolio that includes many of the largest companies operating in the Netherlands and Belgium, whether of national or international origin.

“Hamilton Bright has a strong history of success in improving retail sales in the consumer electronics, body and healthcare, and food sectors,” said Claudio Missaglia, CEO of Hamilton Bright. “We believe that as part of Advantage Smollan we will continue to deliver exceptional results for our clients and to increase the opportunities for our people.”

About Advantage Smollan

Founded in 2015, Advantage Smollan is a jointly-owned holding company of Advantage Solutions (Advantage) and Global Smollan Holdings (Smollan) that provides unified sales, marketing, and technology solutions for consumer goods manufacturers and retailers across Europe. Advantage Smollan offers the industry’s best capabilities and technology along with the local knowledge to address the unique dynamics of individual markets. The company combines Advantage’s and Smollan’s best practices and resources with the extensive experience and market leadership of each portfolio company – all aligned in service excellence, thought leadership, and entrepreneurial spirit to deliver better results for clients and customers. For more information, visit www.advantagesmollan.com. For more information on Advantage, visit www.advantagesolutions.net. For more information on Smollan, visit www.smollan.com.

About Hamilton Bright Group

Hamilton Bright is a shopper sales & marketing specialist, building and strengthening brands on the shop floor for some of the biggest brands in consumer electronics, the food industry, DIY, out of home and personal & healthcare. Hamilton Bright specializes in providing sales, brand activation and marketing intelligence solutions in the Netherlands and Belgium. For additional information, visit www.hamiltonbright.com

Contact information

Advantage Solutions
Will Minton, VP Corporate Marketing
Tel: 949 797 3105
Email: will.minton@advantagesolutions.net
or
Bryce Robinson, General Counsel
Tel: 949 794 2204 Email:
bryce.robinson@advantagesolutions.net
or
Hamilton Bright
Claudio Missaglia, CEO
Tel: +31(0)6 53 215 747
Email: c.missaglia@hamiltonbright.com
or
Global Smollan Holdings
Monique Yaffe, Chief Marketing Officer
Tel: +27 11 458 000
Email: monique.yaffe@smollan.com
or
Advantage Smollan
Laurence Clube, COO
Tel: +44 (0)118927 1010
Email: lclube@advantagesmollan.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme tältä julkaisijalta, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Major Terrorist Plot Foiled in Saudi Arabia, Ministry of Interior Announces21.7.2017 21:33Tiedote

The following is a statement from Saudi Arabia’s Ministry of Culture and Information: This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170721005575/en/ Weapons and other items found in the possession of the three terrorists are an indication of the ugliness and severity of the acts of terrorism they were planning to carry out, victimizing innocent lives and private and public property. (Photo: ME NewsWire) The Saudi Ministry of Interior has announced that a major terrorist attack was prevented by security services in the city of Saihat in the Qatif governorate. On the evening of Friday, July 14th, security services intercepted a stolen Toyota Corolla vehicle in a busy, built-up district of the city. As the stolen vehicle was surrounded by security services, three men in the ca

Janssen Receives Positive CHMP Opinion for SYMTUZA™ The First Darunavir-Based Single-Tablet Regimen for the Treatment of HIV21.7.2017 15:09Tiedote

Janssen-Cilag International NV (Janssen) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a Positive Opinion recommending marketing authorisation for SYMTUZA™ (darunavir/cobicistat/emtricitabine/tenofovir alafenamide [D/C/F/TAF]), a once-daily darunavir-based single tablet regimen (STR). If approved, it will be the only darunavir-based STR indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and adolescents aged 12 years and older with body weight of at least 40 kg, with genotypic testing guiding use. This STR combines the proven efficacy and durability of darunavir with the improved renal laboratory and bone mineral density profile of F/TAF as compared to F/TDF (tenofovir disoproxil fumarate), and will be the only treatment that could deliver the adherence advantag

Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (Telotristat Ethyl), for the Treatment of Carcinoid Syndrome Diarrhea in Patients Inadequately Controlled by Somatostatin Analogue Therapy21.7.2017 14:26Tiedote

Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA), has adopted a positive opinion recommending the approval of Xermelo® (telotristat ethyl) 250 mg three times a day (tid) for the treatment of carcinoid syndrome diarrhea in combination with somatostatin analogue (SSA) therapy in adults inadequately controlled by SSA therapy. The CHMP positive opinion will now be reviewed by the European Commission (EC), which has the authority to approve medicines for use in the 28 countries of the European Union, as well as Norway, Liechtenstein and Iceland. David Meek, Chief Executive Officer of Ipsen, said: “The positive CHMP opinion for Xermelo ® is an important milestone towards providing innovative s

NRI Secure Launches Japan's First "Blockchain Assessment" Service21.7.2017 10:00Tiedote

NRI SecureTechnologies, Ltd. (President: Jun Odashima; hereinafter NRI Secure), a leading provider of information security solutions in Japan, has begun providing Japan’s first-ever*1 “Blockchain Assessment,” a security Assessment service designed for systems and services which use blockchain technology*2. This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170721005012/en/ Overview of the "Blockchain Assessment" Service (Graphic: Business Wire) As the blockchain technology has become more widespread, the presence of security-related vulnerabilities has also become increasingly apparent. In particular, with regard to smart contracts, *3 one of a constituent element of services using the blockchain, a cyberattack carried out on any vulnerable programs could lead to major threats or eve

Business Figures for the First Half of 2017: Sartorius Continues to Grow21.7.2017 08:00Tiedote

Sartorius (FWB:SRT), a leading international laboratory and pharmaceutical equipment supplier, continues on the growth track. In the first half of 2017, solid organic business development and two acquisitions led to a significant increase in sales revenue and earnings1. "Sartorius has continued its dynamic, profitable development," said CEO and Executive Board Chairman Dr. Joachim Kreuzburg in commenting on the company's first-half performance. "Both divisions achieved solid organic growth in an environment that was especially challenging in North America, and have made quick progress in integrating the businesses most recently acquired. In the Lab Products & Services Division, the bioanalytics unit newly created by our acquisitions has already contributed significant revenues and earnings. We see further considerable growth potential ahead for this business just as for the

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme